LOS ANGELES–(BUSINESS WIRE)–Southern California Eye Institute (SCEI) at CHA Hollywood Presbyterian Medical Center (CHA HPMC), a member of CHA Health Systems, a global network providing a full spectrum of dynamic healthcare services, received a gift f…
Author: Business Wire
Global Ophthalmic Viscosurgical Devices Market (2020 to 2025) – Growths, Trends, and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Viscosurgical Devices Market – Growths, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The ophthalmic viscosurgical devices market is expected to register a CAGR…
Worldwide Intraocular Lens Industry to 2025 – Accommodative IOL is Expected to Grow the Fastest – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lens Market – Growth, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The global intraocular lens market is expected to witness a CAGR of 4.9% over the period, 2…
Trefoil Therapeutics to Present Update on Regenerative Treatments for Corneal Diseases
SAN DIEGO–(BUSINESS WIRE)–Trefoil Therapeutics to present update on its first-in-class, engineered FGF-1 regenerative treatments corneal diseases.
Lineage Cell Therapeutics to Host Expert Call Following OpRegen® Data Update at 2020 American Academy of Ophthalmology Meeting
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, will be hosting a call to discuss updated …
IVERIC bio Reports Third Quarter 2020 Operational Highlights and Financial Results
NEW YORK–(BUSINESS WIRE)–IVERIC bio today announced the financial and operating results for the fiscal quarter ended September 30, 2020 and provided a general business update.
Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November 12
EMERYVILLE, Calif.–(BUSINESS WIRE)—- $NBY #Avenova–NovaBay Pharmaceuticals to announce third quarter 2020 financial results on November 12
New Study Shows Use of NeurOptics’ Automated Pupillometry Improves Triage for Patients with Traumatic Brain Injury
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–New study shows NeurOptics’ automated pupillometer can improve triage and expedite treatment for patients with traumatic brain injury.
More Than 40% of Americans Say COVID-19 Has Influenced What Health Plan They Intend to Select During Open Enrollment
MINNETONKA, Minn.–(BUSINESS WIRE)–Many Americans said COVID-19 has influenced the health plan they intend to select during open enrollment, while the majority report they are interested in using a smartphone or laptop to access medical services, acco…
Synedgen Receives Supplemental NEI Funding to Identify Lead Development Candidate for Ocular Mustard Gas Injury Program
CLAREMONT, Calif.–(BUSINESS WIRE)–Synedgen Receives Supplemental NEI Funding to Identify Lead Development Candidate for Ocular Mustard Gas Injury Program
2020 Insights into Retinitis Pigmentosa (RP) – Epidemiology Forecast to 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinitis Pigmentosa (RP) – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the disease, historical and forecasted Retinitis Pigm…
Global Cataract Surgery Devices Market (2020 to 2025) – Growth, Trends, and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract Surgery Devices Market – Growth, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The Cataract Surgery Devices Market is projected to grow with a CAGR of 4.2% over t…
Global Optical Coherence Tomography for Ophthalmology Industry (2020 to 2027) – Market Trends and Drivers – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Coherence Tomography (OCT) for Ophthalmology – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The publisher brings years of research experience to the 6th edit…
IVERIC bio to Participate in Upcoming Virtual Investor / Industry Conferences
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced today that the Company will participate in upcoming virtual investor conferences in November.
Kala Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report th…
Aerie Pharmaceuticals Initiates Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Lineage Cell Therapeutics to Report Third Quarter 2020 Financial Results and Provide Business Update on November 4, 2020
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it will report its th…
COVID-19 Impact: Contact Lenses Market Will Accelerate at a CAGR of over 6% through 2020-2024 | Demand for Disposable Contact Lenses to Boost Growth| Technavio
LONDON–(BUSINESS WIRE)– #ContactLensesMarket–The Global Contact Lenses Market will grow by USD 4.55 bn during 2020-2024
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and Rocklatan® in Japan and Several Other Asian Countries
OSAKA, Japan & DURHAM, N.C.–(BUSINESS WIRE)–Santen Pharmaceutical Co., Ltd. (“Santen”) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Santen and Aerie have entered into an exclusive development and commercialization agreement …